Virtual Reality for Pain and Well-Being in Older Adults (VitaMove)
Moving Without Fear or Pain: Use of Immersive Virtual Reality to Reduce Pain and Improve Well-Being in Older Adults
Chronic pain is common among adults aged 65 and older and can reduce mobility, independence, mood, and quality of life. Many older adults also develop a fear of movement because they worry that physical activity will increase their pain or cause injury. This fear can lead to reduced activity, physical deconditioning, and further loss of independence. This study aims to evaluate the feasibility, acceptability, and potential impact of Moving Without Fear or Pain, a program using immersive virtual reality rehabilitation to gradually reintroduce movement in a safe and engaging way.
The virtual reality intervention includes up to eight individualized sessions over approximately one month. Sessions last 5 to 30 minutes and are supervised by a trained clinician. Participants wear a virtual reality headset and are immersed in calming or engaging environments, such as nature settings. Depending on their comfort and abilities, sessions may begin with passive guided motor imagery and progress to active movement within interactive virtual environments. Some applications allow participants to control movement in the virtual world through gentle physical activity, such as stepping or upper-body movement. The intervention is personalized to each participant's physical capacity, preferences, and rehabilitation goals. The aim is to reduce fear of movement, increase confidence, and promote safe re-engagement in physical activity. In this pilot randomized controlled trial, 24 older adults with chronic pain will be randomly assigned to one of two groups: 1) Experimental Group: Participants will receive care, and up to eight immersive virtual reality rehabilitation sessions. 2) Control Group: Participants will receive usual care, without virtual reality sessions. The findings will inform a larger future study.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Chronic pain in older adults is a complex and multidimensional condition that affects physical function, emotional well-being, social participation, and overall quality of life. In this population, persistent pain is frequently accompanied by fear of movement and maladaptive beliefs about pain, which can lead to activity avoidance and progressive functional decline. Many older adults reduce their physical activity not only because of pain itself, but because of the anticipation that movement will worsen symptoms or cause injury. Over time, this avoidance can contribute to muscular deconditioning, reduced balance, increased frailty, and greater dependence in daily activities.
This study is grounded in the biopsychosocial model of chronic pain, which integrates biological, psychological, and social contributors to the pain experience. The intervention is designed to engage these interacting domains simultaneously. On a biological level, gradual activation of the motor system and re-engagement in movement may help counteract deconditioning. On a psychological level, reducing fear-based avoidance may improve confidence and perceived control. On a social and emotional level, increasing engagement and exposure to meaningful environments may support mood and motivation.
Immersive virtual reality offers a novel therapeutic platform capable of supporting graded exposure to movement in a controlled and engaging manner. Immersive virtual environments create a strong sense of presence, meaning that users feel situated within the simulated environment rather than observing it from a distance. This immersive quality may increase attentional absorption, reduce pain salience, and enhance emotional engagement. Virtual environments can also provide positive and calming experiences, including exposure to natural landscapes, which have been associated with improved mood and reduced stress. In addition, interactive virtual systems can translate gentle physical movements into forward progression within the environment, allowing participants to experience movement success in a supportive context.
The intervention evaluated in this study integrates immersive virtual reality rehabilitation session. The virtual component is personalized and adapted to the participant's functional capacity, preferences, and rehabilitation goals. The progression within the immersive experience is gradual. Participants may begin with exposure to immersive environments that require no active physical movement, allowing them to become comfortable with the technology and to engage in guided motor imagery. As confidence increases, the intervention may incorporate gentle physical movements that influence navigation within the virtual space. This graded approach is designed to reduce fear while reinforcing positive movement experiences. The immersive environments are selected to promote safety, engagement, and enjoyment, with careful monitoring for tolerability.
The primary purpose of this pilot study is not to establish definitive clinical efficacy, but rather to evaluate feasibility, acceptability, and implementation practicality in older adults with chronic pain. The study seeks to determine whether the combined approach can be delivered safely within clinical and residential care settings, whether participants are willing to engage with immersive technology, and whether clinicians can integrate the intervention into routine workflows. The study also aims to estimate variability in key clinical measures in order to inform sample size calculations for a future larger trial.
Several conceptual mechanisms may contribute to potential benefit. Engagement in immersive environments may reduce attentional focus on pain, temporarily lowering perceived intensity. Guided motor imagery and graded movement may activate motor-related neural networks without triggering excessive threat responses. Repeated positive movement experiences may weaken fear-based associations. Improvements in confidence and perceived control may facilitate behavioral activation and adherence to rehabilitation. Exposure to calming natural environments may influence mood and stress regulation. These interacting processes reflect the integrated biopsychosocial rationale of the intervention.
The pilot design allows systematic documentation of recruitment flow, adherence patterns, participant retention, tolerability of immersive exposure, and practical barriers to implementation. The study also examines whether older adults with varying levels of physical function and technological familiarity can engage with immersive systems when provided appropriate supervision and support. Safety considerations are central, including monitoring for cybersickness symptoms such as dizziness, nausea, or disorientation. The intervention is delivered under trained supervision, and participants may discontinue at any time without impact on usual care.
By focusing on feasibility and implementation in real-world contexts rather than tightly controlled laboratory conditions, the study aims to generate information that is directly relevant to clinical translation. The results will inform refinement of procedures, optimization of session pacing, identification of appropriate safety parameters, and clarification of training needs for clinicians. Ultimately, this pilot phase is intended to support the development of a larger, adequately powered randomized controlled trial designed to evaluate the clinical effectiveness of immersive virtual reality-supported rehabilitation for chronic pain in older adults.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Martine Bordeleau, PhD
- 電話番号:1-581-490-2626
- メール:martine.bordeleau@outlook.com
研究場所
-
-
Quebec
-
Québec、Quebec、カナダ
- 募集
- CIUSSS de la Capitale-Nationale
-
コンタクト:
- Line D'Amours (coordinatrice CEVQ)
- 電話番号:418-906-7465
- メール:line.damours.ciussscn@ssss.gouv.qc.ca
-
Sainte-Marie、Quebec、カナダ
- 募集
- CISSS de Chaudière-Appalaches
-
コンタクト:
- Louis-Frédéric Lessard (conseiller en milieux de vie)
- 電話番号:48135 418-387-8181
- メール:louis-frederic.lessard.cisssca@ssss.gouv.qc.ca
-
-
参加基準
適格基準
適格基準
就学可能な年齢
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Age 65 years or older
- Able to understand and communicate in French
- Chronic pain lasting 6 months or longer
- Average pain intensity of 3 or greater on a 0-10 Numeric Rating Scale during the week prior to enrollment
- Score greater than 25 on the 11-item Tampa Scale of Kinesiophobia (TSK-11)
- No neurocognitive impairment (Mini-Mental State Examination [MMSE] ≥ 24), or mild neurocognitive impairment (MMSE 18-24) with preserved capacity to consent (University of California Brief Assessment of Capacity to Consent [UBACC] score ≥ 12)
- Normal or corrected-to-normal visual acuity
Exclusion Criteria:
- Severe motion sickness or intolerance that would prevent safe use of a virtual reality headset (experimental group only)
- Medical condition that would prevent safe participation in rehabilitation activities
- Presence of open wounds or infection at painful or contralateral sites
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Virtual Reality and Usual Care
Participants receive usual care and up to eight individualized immersive virtual reality rehabilitation sessions delivered over approximately one month.
Virtual reality sessions are supervised by trained clinicians and may include guided motor imagery, immersive nature environments, and graded interactive movement adapted to participant capacity and goals.
|
Immersive virtual reality rehabilitation sessions delivered under clinician supervision, using guided motor imagery, immersive natural environments, and graded interactive movement adapted to participant capacity and goals. Following completion of the educational session, participants engage in immersive virtual reality rehabilitation delivered under clinician supervision. The virtual reality component uses a head-mounted display to immerse par
他の名前:
Participants continue to receive their usual care throughout the study period.
|
|
アクティブコンパレータ:Usual Care
Participants receive usual care.
|
Participants continue to receive their usual care throughout the study period.
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Kinesiophobia as Measured by the Tampa Scale of Kinesiophobia (TSK-11)
時間枠:Baseline (pre-intervention) to post-intervention (after completion of the 8 rehabilitation sessions, approximately 4 weeks)
|
Kinesiophobia will be assessed using the 11-item Tampa Scale of Kinesiophobia (TSK-11).
Scores range from 11 to 44, with higher scores indicating greater fear of movement.
The primary analysis will evaluate change in TSK-11 score from baseline to post-intervention.
|
Baseline (pre-intervention) to post-intervention (after completion of the 8 rehabilitation sessions, approximately 4 weeks)
|
|
Feasibility of the Multimodal Intervention
時間枠:Throughout the study period (from recruitment through post-intervention assessment, approximately 4-8 weeks)
|
Feasibility will be evaluated using recruitment rate (proportion of eligible individuals who consent), adherence (proportion of intervention sessions completed), retention/attrition rate (proportion of participants completing the study), and documentation of adverse events and protocol deviations.
|
Throughout the study period (from recruitment through post-intervention assessment, approximately 4-8 weeks)
|
|
Acceptability of the Multimodal Intervention
時間枠:Throughout the study period (from recruitment through post-intervention assessment, approximately 4-8 weeks)
|
Acceptability will be assessed using structured participant and clinician questionnaires administered before and after the intervention, including Likert-scale ratings of satisfaction, perceived usefulness, usability of virtual reality, and perceived barriers to participation.
|
Throughout the study period (from recruitment through post-intervention assessment, approximately 4-8 weeks)
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Fear-Avoidance Beliefs as Measured by the Fear Avoidance Component Scale (FACS)
時間枠:Baseline to post-intervention (approximately 4 weeks)
|
Fear-avoidance beliefs will be assessed using the Fear Avoidance Component Scale (FACS), a self-reported questionnaire designed to comprehensively measure fear-avoidance components in individuals with painful medical conditions.
The FACS includes 20 items, each rated on a Likert scale from 0 = completely disagree to 5 = completely agree.
The total score is calculated by summing all item scores and ranges from 0 to 100.
Higher scores indicate worse outcomes, namely greater fear-avoidance beliefs and behaviors related to pain and movement.
Scores can be categorized into five severity levels: Subclinical = 0 to 20, Mild = 21 to 40, Moderate = 41 to 60, Severe = 61 to 80, and Extreme = 81 to 100.
|
Baseline to post-intervention (approximately 4 weeks)
|
|
Change in Emotional State as Measured by the Profile of Mood States (POMS)
時間枠:Baseline to post-intervention (approximately 4 weeks)
|
Emotional state will be assessed using the Profile of Mood States (POMS), a self-reported questionnaire that evaluates mood across six domains: tension-anxiety, depression-dejection, anger-hostility, fatigue-inertia, vigor-activity, and confusion-bewilderment.
The POMS includes 65 items, each rated on a 5-point scale from 0 = not at all to 4 = extremely.
The Total Mood Disturbance score is calculated by summing the negative mood subscales - tension-anxiety, depression-dejection, anger-hostility, fatigue-inertia, and confusion-bewilderment - and subtracting the vigor-activity score.
The possible Total Mood Disturbance score ranges from -32 to 200.
Higher Total Mood Disturbance scores indicate worse outcomes, reflecting greater overall emotional distress.
For individual subscales, higher scores indicate worse outcomes for the negative mood domains and better outcomes for the vigor-activity domain.
Subscale score ranges are as follows: tension-anxiety, 0 to 36; depression-dejection, 0
|
Baseline to post-intervention (approximately 4 weeks)
|
|
Change in Pain Catastrophizing as Measured by the Pain Catastrophizing Scale (PCS)
時間枠:Baseline to post-intervention (approximately 4 weeks)
|
Pain-related catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS).
Total scores range from 0 to 52, with higher scores indicating greater levels of rumination, magnification, and helplessness related to pain.
The outcome measure will evaluate change in PCS score from baseline to post-intervention.
|
Baseline to post-intervention (approximately 4 weeks)
|
|
Self-Reported Percentage of Pain Relief
時間枠:Post-intervention (approximately 4 weeks)
|
Participants will report the percentage of overall pain relief experienced following the intervention.
Responses will range from 0% (no relief) to 100% (complete relief).
This measure captures perceived global improvement in pain.
|
Post-intervention (approximately 4 weeks)
|
|
Cybersickness as Measured by the Simulator Sickness Questionnaire (SSQ)
時間枠:Assessed during and after virtual reality sessions (up to approximately 4 weeks)
|
Tolerance to immersive virtual reality will be assessed using the Simulator Sickness Questionnaire (SSQ), a widely used tool for measuring cybersickness symptoms in virtual environments.
The SSQ assesses three main dimensions: nausea, oculomotor symptoms, such as visual fatigue, and disorientation.
The SSQ includes 16 symptoms, each rated from 0 = none to 3 = severe.
The weighted total score ranges from 0 to 179.52, with higher scores indicating worse outcomes, meaning greater severity of cybersickness symptoms.
|
Assessed during and after virtual reality sessions (up to approximately 4 weeks)
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- 主任研究者:Maude Laberge, PhD、Laval University
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- MP-31-2026-6028
- RQRV (その他の識別子:Network for Research on Aging)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有アクセス基準
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。